1)Morales A and Lunenfeld B:International Society for the Study of the Aging Male:Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male. Aging Male 5(2):74-86, 2002
2)「LOH症候群診療ガイドライン」検討ワーキング委員会:加齢男性性腺機能低下症候群診療の手引き.じほう,東京,2007
3)河 源,谷口久哲,木下秀文,他:男性更年期専門外来の受診患者像に関する検討—5年間の臨床統計と年次における変遷.泌尿紀要55:87-92,2009
4)Heinemann LAJ, Zimmermann T, Vermeulen A, et al:A new‘aging male's symptoms’rating scale. Aging Male 2:105-114, 1999
5)日本性機能学会用語委員会:国際勃起能スコア(IIEF)と国際勃起機能スコア5(IIEF5)の日本語訳.IMPOTENCE 13:35-38,1998
6)Fukuhara S, Suzukamo Y, Bito S, et al:Manual of SF-36 Japanese version 1.2:Public Health Reserch Foundation, Tokyo, 2001
7)Okada K, Yamaguchi K, Chiba K, et al:Comprehensive evaluation of androgen replacement therapy in aging Japanese men with late-onset hypogonadism. Aging Male 17:72-75, 2014
8)Yassin DJ, Doros G, Hammerer PG, et al:Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life. J Sex Med 11:1567-1576, 2014
9)Zitzmann M, Mattern A, Hanisch J, et al:IPASS:a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 men. J Sex Med 10:579-588, 2013
10)Tracz MJ, Sideras K, Boloña ER, et al:Testosterone use in men and its effects on bone health:a systematic review and meta-analysis of randomized placebo-controlled trials. J Clin Endocrinol Metab 91:2011-2016, 2006
11)Lunenfeld B, Mskhalaya G and Kalinchenko S:Recommendations on the diagnosis, treatment and monitoring of late-onset hypogonadism in men:a suggested update. Aging Male 16(4):143-150, 2013
12)Tsujimura A, Takada S, Matsuoka Y, et al:Is discontinuation of hormone replacement therapy possible for patients with late-onset hypogonadism? Int J Urol 15:625-629, 2008
13)Taniguchi H, Kawa G, Kinoshita H, et al:Symptomatic change in Japanese hypogonadal patients several years after androgen replacement therapy. Aging Male 14(3):190-194, 2011